| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |